Tenet Healthcare Corporation operates as a diversified healthcare services company. More Details
Moderate growth potential with mediocre balance sheet.
Share Price & News
How has Tenet Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: THC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: THC's weekly volatility (11%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: THC exceeded the US Healthcare industry which returned 13.5% over the past year.
Return vs Market: THC exceeded the US Market which returned 21% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Tenet Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StCalculating The Intrinsic Value Of Tenet Healthcare Corporation (NYSE:THC)
1 month ago | Simply Wall StWhy Tenet Healthcare's (NYSE:THC) CEO Pay Matters
1 month ago | Simply Wall StDid You Miss Tenet Healthcare's (NYSE:THC) Impressive 141% Share Price Gain?
Is Tenet Healthcare undervalued compared to its fair value and its price relative to the market?
Share Price vs. Fair Value
Below Fair Value: THC ($47.38) is trading above our estimate of fair value ($45)
Significantly Below Fair Value: THC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: THC is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: THC is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate THC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: THC has negative assets, so we can't compare its PB Ratio to the US Healthcare industry average.
How is Tenet Healthcare forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: THC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: THC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: THC's is expected to become profitable in the next 3 years.
Revenue vs Market: THC's revenue (6.2% per year) is forecast to grow slower than the US market (10.2% per year).
High Growth Revenue: THC's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: THC's Return on Equity is forecast to be low in 3 years time (14.8%).
How has Tenet Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: THC is currently unprofitable.
Growing Profit Margin: THC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: THC is unprofitable, but has reduced losses over the past 5 years at a rate of 10.4% per year.
Accelerating Growth: Unable to compare THC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: THC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (21.4%).
Return on Equity
High ROE: THC has a negative Return on Equity (16.44%), as it is currently unprofitable.
How is Tenet Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: THC's short term assets ($7.8B) exceed its short term liabilities ($5.8B).
Long Term Liabilities: THC's short term assets ($7.8B) do not cover its long term liabilities ($18.3B).
Debt to Equity History and Analysis
Debt Level: THC's debt to equity ratio (749.9%) is considered high.
Reducing Debt: THC's debt to equity ratio has increased from 544% to 749.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable THC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: THC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 51.2% per year.
What is Tenet Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate THC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate THC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if THC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if THC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of THC's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ron Rittenmeyer (73 yo)
Mr. Ronald A. Rittenmeyer, also known as Ron, has been Director of IQVIA Holdings Inc. since October 2016. He served as Director of IMS Health from April 2010 to October 2016. He has been Executive Chairma...
CEO Compensation Analysis
Compensation vs Market: Ron's total compensation ($USD24.29M) is above average for companies of similar size in the US market ($USD6.20M).
Compensation vs Earnings: Ron's compensation has increased whilst the company is unprofitable.
|Executive Chairman & CEO||3.25yrs||US$24.29m||0.59% |
|CFO & Executive VP||8.33yrs||US$5.14m||0.32% |
|Executive VP & Chief Information Officer||2.67yrs||US$1.70m||0.0025% |
|Executive VP||8yrs||US$3.64m||0.049% |
|Vice President of Investor Relations||1.17yrs||no data||no data|
|Executive VP & Chief Compliance Officer||4.67yrs||no data||0% |
|Executive VP of Communications & Chief Marketing Officer||1.83yrs||no data||0.0049% |
|Senior Vice President of Corporate Development||3.92yrs||no data||no data|
|Executive VP & Chief Human Resources Officer||3.17yrs||no data||0.0079% |
|Chief Financial Officer of Nola Regional Health Network||no data||no data||no data|
|Chief Managed Care Officer & Senior VP||13.5yrs||no data||no data|
Experienced Management: THC's management team is considered experienced (3.3 years average tenure).
|Executive Chairman & CEO||3.25yrs||US$24.29m||0.59% |
|Independent Director||3.25yrs||US$307.50k||no data|
|Independent Director||2.67yrs||US$292.50k||0.0058% |
|Lead Independent Director||3.25yrs||US$508.30k||0.034% |
|Independent Director||3.17yrs||US$299.00k||no data|
|Independent Director||3.17yrs||US$300.50k||no data|
|Independent Director||5.83yrs||US$306.24k||0.025% |
|Independent Director||1.42yrs||US$243.21k||no data|
|Executive Chairman of Aspen Healthcare||no data||no data||no data|
|Independent Director||2.67yrs||US$302.50k||no data|
|Independent Director||1.25yrs||US$190.22k||0.00095% |
Experienced Board: THC's board of directors are considered experienced (3.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: THC insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Tenet Healthcare Corporation's company bio, employee growth, exchange listings and data sources
- Name: Tenet Healthcare Corporation
- Ticker: THC
- Exchange: NYSE
- Founded: 1975
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$4.935b
- Shares outstanding: 105.52m
- Website: https://www.tenethealth.com
Number of Employees
- Tenet Healthcare Corporation
- 1445 Ross Avenue
- Suite 1400
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|THC||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Apr 1971|
|THC1||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Apr 1971|
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hos...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/15 23:11|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.